Table 1. Baseline characteristics of children who provided a post-treatment stool sample at follow up compared to those children who were lost at follow up.
Number of children | Age (year) (mean ± SD) |
Sex (% boys) |
Ascaris
|
Trichuris
|
Hookworm |
||||
---|---|---|---|---|---|---|---|---|---|
Prevalencea | Egg countb | Prevalencea | Egg countb | Prevalencea | Egg countb | ||||
Mebendazole | |||||||||
Sample | 448 | 9·5 ± 1·9 | 46·4 | 23·9 | 5 | 90·2 | 257 | 94·6 | 588 |
Lost at follow-up | 38 | 9·8 ± 2·1 | 63·2 | 42·1 | 29 | 94·7 | 329 | 92·1 | 745 |
P | NS | 0·04 | 0·01 | 0·007 | NS | NS | NS | NS | |
Pyrantel-oxantel | |||||||||
Sample | 440 | 9·5 ±1·8 | 47·5 | 22·8 | 5 | 86·8 | 213 | 93·4 | 571 |
Lost at follow-up | 38 | 9·4±1·9 | 52·6 | 23·7 | 5 | 86·8 | 252 | 94·7 | 777 |
P | NS | NS | NS | NS | NS | NS | NS | NS | |
Placebo | |||||||||
Sample | 441 | 9·4 ± 1·5 | 39·9 | 23·4 | 5 | 83·7 | 163 | 94·6 | 573 |
Lost at follow-up | 30 | 9·2 ± 1·4 | 50·0 | 23·3 | 4 | 90·0 | 200 | 93·3 | 571 |
P | NS | NS | NS | NS | NS | NS | NS | NS | |
Total | |||||||||
Sample | 1329 | 9·4 ± 1·3 | 44·6 | 23·4 | 5 | 86·9 | 208 | 94·2 | 577 |
Lost at follow-up | 106 | 9·5 ± 1·4 | 55·7 | 30·2 | 9 | 90·6 | 260 | 93·4 | 701 |
P | NS | 0·03 | NS | NS | NS | NS | NS | NS |
NS, Not Significant.
Percentage positive.
Eggs per gram expressed as geometric mean.